Holdings  > Holding Rationales  > Medical device company with di...

Holding: BSX

lycos14 [1185] Star!Star!

Symbol Sector Return Exposure Trades Last Trade Status
BSX Medical Supplies 27.20%  n/a 3  08-Oct-08  Prior Holding
<< Previous Post     Next Post >>

02-Jul-08

Medical device company with dim prospects

Holding Rationale for BSX.

BSX was a top performing stock during the bear market of 2000-2002. It rose from below $7 to above $44. From its peak, BSX has drifted downward and now sits around $12/share.

The stock would be lower today if it wasn't for its attractive (backward looking) valuation. It trades just over 2x sales and 1x book.

From a fundamental perspective, however, Boston Scientific is struggling. It is facing increased competition and has failed to come up with blockbuster products (nor do any appear on the horizon, especially since they are using R&D as one area to enact cost cutting). Revenues for this year and next are expected to be below 2007 numbers. And considering the firm does approximately $8b in annual sales, marginal gains in one or two segments will not be enough to propel the stock much higher.

A macro look at the industry is less than promising. With the medical issues regarding coronary stents, growth will be stagnant and may possibly turn negative over the next few years. Considering BSX has the dominant share in this segment, additional organic growth for the firm from this area is unlikely.

Earnings estimates have actually moved up slightly, and while BSX will never trade at a severely depressed valuation, I think we'll see a price below $10 before we see $16. My longer-term price target is around $8/share, which equates to approx 15x 2009 earnings of $0.55 (lower end of estimates). Longer-term, BSX's lack of revenue growth should be the key driver of the struggling share price. Earnings that come from deleveraging, lowered costs, and margin expansion are not sustainable.

Tagged Stocks: BSX

 

Posted at 05:32 in Holding Rationales  |   Permalink  |   Comments ()     |  Top

AddThis Social Bookmark Button
 
 
 

Credibility in BSX

lycos14

BSX Out
Rank 1/19
Return 27.20% at 2008-12-01
Rank 1/19
Trades 3
Followers 92
 

Categories

Holding Rationales (53)

Market Report (50)

Strategy (1)

Holding Tags

AEO (1)

AFSI (3)

ALB (3)

AW (3)

BSX (1)

CAKE (1)

CHK (1)

CTX (3)

DO (5)

EWA (3)

EWY (2)

FLIR (2)

GLD (3)

JNJ (1)

MS (1)

OFG (3)

ORCL (1)

PFE (1)

POT (1)

RIMM (5)

SLW (1)

SPY (1)

TEX (4)

TPX (3)

VCGH (5)

VCLK (2)

WDC (2)

WFC (3)

WRC (1)

YGE (1)

Other Stock Tags

AAPL (1)

AET (1)

AMZN (1)

BAC (2)

BUCY (1)

CPST (3)

DOW (1)

EBAY (1)

ED (1)

EXPO (1)

FAF (1)

FCX (1)

FLS (1)

HANS (2)

HNT (1)

HP (1)

HUM (1)

ISRG (1)

MSFT (1)

MU (1)

NOK (1)

RSG (1)

RTN (1)

SLE (1)

STX (1)

VMW (1)

VZ (1)

WBS (1)

WLP (1)

WW (2)

 

Archives

Oct 2008 (1)

Aug 2008 (1)

Jul 2008 (4)

Jun 2008 (3)

May 2008 (3)

Apr 2008 (7)

Mar 2008 (4)

Feb 2008 (3)

Jan 2008 (8)

Dec 2007 (8)

Nov 2007 (5)

Oct 2007 (20)

Sep 2007 (10)

Aug 2007 (13)

Jul 2007 (8)

Jun 2007 (5)

Mar 2007 (1)